CM
Caption Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4M | Buy |
230,888
+218,888
| +1,824% | +$3.79M | 0.04% | 60 |
|
|
2025
Q1 | $262K | Buy |
+12,000
| New | +$262K | ﹤0.01% | 365 |
|
|
2024
Q4 | – | Sell |
-216,006
| Closed | -$6.23M | – | 539 |
|
|
2024
Q3 | $6.23M | Sell |
216,006
-213,994
| -50% | -$6.17M | 0.1% | 23 |
|
|
2024
Q2 | $16.5M | Buy |
430,000
+399,000
| +1,287% | +$15.3M | 0.25% | 9 |
|
|
2024
Q1 | $1.82M | Sell |
31,000
-362,031
| -92% | -$21.3M | 0.03% | 97 |
|
|
2023
Q4 | $23.5M | Buy |
393,031
+119,781
| +44% | +$7.17M | 0.32% | 5 |
|
|
2023
Q3 | $10.4M | Buy |
273,250
+273,026
| +121,887% | +$10.4M | 0.16% | 14 |
|
|
2023
Q2 | $20.4K | Buy |
+224
| New | +$20.4K | ﹤0.01% | 319 |
|
|
2023
Q1 | – | Sell |
-17,000
| Closed | -$879K | – | 370 |
|
|
2022
Q4 | $879K | Buy |
+17,000
| New | +$879K | 0.01% | 159 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 526 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 498 |
|
|
2022
Q1 | – | Sell |
-220,000
| Closed | -$10.4M | – | 534 |
|
|
2021
Q4 | $10.4M | Buy |
220,000
+198,557
| +926% | +$9.39M | 0.12% | 31 |
|
|
2021
Q3 | $707K | Sell |
21,443
-49,057
| -70% | -$1.62M | 0.01% | 306 |
|
|
2021
Q2 | $4.46M | Buy |
70,500
+65,500
| +1,310% | +$4.14M | 0.06% | 50 |
|
|
2021
Q1 | $214K | Buy |
+5,000
| New | +$214K | ﹤0.01% | 287 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 321 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 355 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 319 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 324 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 302 |
|